• EdU Imaging Kits (HF488) for Cell Proliferation

  2026-08-29

  EdU Imaging Kits (HF488) use 5-ethynyl-2'-deoxyuridine incorporation and click chemistry to measure DNA synthesis during S phase. The K2240 workflow supports fluorescence microscopy and flow cytometry with a fluorescent HyperFluor™ 488 readout and avoids the DNA-denaturation step used in conventional BrdU detection.

• Engineering the Cas9 mRNA Window for Precision

  2026-08-28

  Precision genome editing depends not only on guide design and nuclease fidelity, but also on how long Cas9 is translated, where its mRNA travels, and how the innate immune system responds. This thought-leadership article connects Cap1 capping, N1-Methylpseudo-UTP modification, poly(A) tailing, and nuclear-export control to practical CRISPR-Cas9 workflow design. It also explains where EZ Cap™ Cas9 mRNA (m1Ψ) fits, how to benchmark it responsibly, and why transient mRNA control is strategically important for translational researchers.

• Direct Mouse Genotyping Kit for GEMM Assays

  2026-08-28

  The Direct Mouse Genotyping Kit simplifies PCR amplification from mouse tissue for genetically engineered mesothelioma models. This guide explains how to align direct lysate PCR with allele design, conditional recombination, quality control, and high-throughput mouse genetic screening.

• Telmisartan in Angiotensin II Cardiac Research

  2026-08-27

  Telmisartan is an angiotensin II receptor antagonist used as an AT1-receptor perturbation tool in hypertension research compound workflows. Its defined chemical profile and DMSO compatibility support cardiovascular disease research, while RIP3/CaMKII findings from an isochlorogenic acid A study should not be attributed directly to telmisartan.

• Recombinant Annexin V for Apoptosis Detection

  2026-08-27

  Brumatti, Sheridan, and Martin established a practical bacterial expression, purification, and FITC-labeling workflow for recombinant annexin V. The study shows how a soluble polyhistidine-tagged protein can provide a reproducible probe for phosphatidylserine exposure in apoptotic cells, with applications in flow cytometry and fluorescence microscopy.

• TBST Workflows for Clearer Immunoassay Signals

  2026-08-26

  TBST supports reproducible blocking, antibody dilution, and washing across Western blot, immunofluorescence, immunohistochemistry, and immunocytochemistry workflows. This guide connects its detergent-controlled assay role with a published uPAR·uPA inhibitor study, showing how disciplined washing and background control can strengthen mechanistic readouts without overstating what the buffer proves.

• Carbenoxolone disodium: Workflow and QC Guide

  2026-08-26

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled cell- and tissue-based studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is suitable for mechanistic workflows with solvent, viability, and pathway controls, but should not be treated as a selective in vivo efficacy agent or a validated treatment for disease models.

• Cy7 NHS Ester: Practical Labeling and QC Guide

  2026-08-25

  Cy7 NHS ester (A8109) is a water-soluble, sulfonated protein labeling dye for attaching near-infrared fluorescence to primary amino groups in proteins and peptides. It is suited to aqueous biomolecule conjugation and near-infrared fluorescent imaging, but prepared solutions should be used promptly and labeling conditions must be optimized for each target.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-08-25

  This 2015 study describes indazole- and indole-based glucagon receptor antagonists derived from the MK-0893 design concept. Its integrated scaffold optimization, structure–activity relationship analysis, pharmacokinetic testing, and acute humanized-mouse studies identified compounds with promising early pharmacological profiles, including orally active GRA 16d.

• Ionomycin Free Acid as a Calcium Causality Probe

  2026-08-24

  Ionomycin free acid is a calcium ionophore for controlled intracellular calcium increase and mechanistic cell biology. This article explains how to use it as a causal probe for the FAISL–FAK–calpain axis in triple-negative breast cancer research while separating established findings from testable hypotheses.

• AZD3463 Workflow for ALK/IGF1R Studies

  2026-08-23

  Build reproducible neuroblastoma experiments around AZD3463 by linking ALK/IGF1R blockade to PI3K/AKT/mTOR signaling, apoptosis, autophagy, and chemotherapy response. The workflow also shows how a breast-cancer pathway study can inspire carefully bounded assay extensions without overstating cross-model evidence.

• TUNEL Readouts for Macrophage Cell Death

  2026-08-22

  Macrophage death is not a single biological endpoint: inflammatory stimuli can redirect cells toward apoptosis or pyroptosis. This thought-leadership guide explains how TUNEL-based DNA fragmentation readouts, anchored to the MST1/2 macrophage study, can strengthen translational experimental design without overstating what TUNEL alone can prove.

• High-Throughput BBB Screening with LLC-PK1-MDR1

  2026-08-21

  Hu and colleagues developed a Transwell surrogate blood-brain barrier model combining LLC-PK1-MOCK and LLC-PK1-MDR1 cells with a correction for lysosomal trapping. Across 41 compounds, the platform linked in vitro permeability to in vivo unbound brain distribution and provided a scalable approach for prioritizing CNS drug candidates.

• Single-Cell RNA Isoforms in Alzheimer’s Disease

  2026-08-21

  This study combines 10X Genomics single-nucleus profiling with PacBio Kinnex long-read sequencing to resolve full-length RNA isoforms in post-mortem Alzheimer’s disease and non-diseased human cortex. The findings show extensive cell-type-specific isoform diversity, disease-associated transcript changes, and isoform switching that are not readily captured by conventional short-read approaches.

• 15-PGDH Inhibition and Muscle Recovery During Weight Loss

  2026-08-20

  This 2026 PNAS study identifies 15-PGDH inhibition as a strategy for improving muscle repair and force recovery during semaglutide-associated weight loss in obese mice. The work separates successful body-weight reduction from preservation of regenerative muscle quality, showing that combined treatment enhances muscle stem cell activity and regenerated myofiber growth without weakening semaglutide’s weight-loss effect.

446 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page